M&A Deal Summary |
|
|---|---|
| Date | 2024-07-01 |
| Target | DeltaMed Solutions |
| Sector | Life Science |
| Buyer(s) | HiRO |
| Deal Type | Add-on Acquisition |
SEARCH BY
HiRO is a clinical research organization (CRO). With global operations and integration capabilities, HiRO provides a full range of cross-border solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design, regulatory, pharmacovigilance, statistics, data management, end-to-end project management, and clinical and medical monitoring services. HiRO was founded in 2020 and is based in Shanghai, China.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-08-31 |
Courante Oncology
Excelsior, Minnesota, United States Courante Oncology is a full-service clinical research provider specializing in oncology product development. The company offers a wide range of clinical trial management and support services to the pharmaceutical and medical device industries, including project management, clinical site monitoring, quality assurance, and medical writing services. Courante Oncology was founded in 1999 and is based in Excelsior, Minnesota. |
Buy | - |
